Literature DB >> 16874991

Incidence of pterygium recurrence in patients treated with thio-tepa.

G A Joselson1, P Muller.   

Abstract

Our experience with thio-tepa was quite encouraging. We used the agent in 46 eyes postoperatively. In only one case of 21 primary pterygia was there a recurrence. In 11 patients with a pterygium in each eye, there was recurrence in three of 11 untreated eyes and no recurrence in 11 treated eyes. Our follow-up is from six months, for the most recent cases, to 18 months. In the concentration used in this study, the postoperative reaction remained in 39 of 46 treated eyes while the drug was used. After treatment was completed, the eyes became white in a short time. Our results indicate that thio-tepa is effective in reducing the percentage of recurrence of pterygia of all types.

Entities:  

Mesh:

Substances:

Year:  1966        PMID: 16874991

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  5 in total

1.  Postoperative subconjunctival 5-fluorouracil in the management of recurring pterygium.

Authors:  Anupama Pherwani; Vipul Vakil; Habibullah Eatamadi; Ravinder Singh; Harminder S Dua
Journal:  Br J Ophthalmol       Date:  2007-03       Impact factor: 4.638

2.  Does topical bevacizumab prevent postoperative recurrence after pterygium surgery with conjunctival autografting?

Authors:  Aylin Karalezli; Cem Kucukerdonmez; Yonca A Akova; Bengu Ekinci Koktekir
Journal:  Int J Ophthalmol       Date:  2014-06-18       Impact factor: 1.779

3.  Pterygium removal. A technique to prevent recurrence.

Authors:  A U Herbstein; J K Donovan
Journal:  Br J Ophthalmol       Date:  1968-02       Impact factor: 4.638

4.  Role of mitomycin C in pterygium surgery.

Authors:  P S Mahar; G E Nwokora
Journal:  Br J Ophthalmol       Date:  1993-07       Impact factor: 4.638

5.  Conjunctivolimbal autograft using a fibrin adhesive in pterygium surgery.

Authors:  Hyun Ho Kim; Hong Jae Mun; Young Jeung Park; Kyoo Won Lee; Jae Pil Shin
Journal:  Korean J Ophthalmol       Date:  2008-09
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.